GEN3018 / Genmab - LARVOL DELTA

First-in-human (FIH) Trial of GEN3018 in Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML) or Higher-risk Myelodysplastic Syndrome (HR-MDS) (clinicaltrials.gov) - P1 | N=78 | Recruiting | Sponsor: Genmab | Not yet recruiting ➔ Recruiting

Enrollment open • First-in-human • Acute Myelogenous Leukemia • Hematological Malignancies • Leukemia • Myelodysplastic Syndrome • Oncology